Anne was Senior Associate at Sofinnova Partners (2013-2017). She brings more than 15 years of experience in the Life Sciences sector, acquired as a Business Development Executive at Cancer Research Technology (2007-2013) and Senior Medicinal Chemist at Cambridge Biotechnology Ltd (2003-2007). Anne’s experience includes equity financing (seed and series A), tech transfer & scouting, business development and biotech R&D.

Anne carried out postdoctoral research at Yale University after gaining her PhD in organic chemistry from the University of Bristol. She holds a diplôme d’ingénieur from the Institut National des Sciences Appliquées de Rouen, specialising in Chemistry. She is an author on seven peer-reviewed papers and an inventor on eight patent families. As part of the investment team at Sofinnova Partners, Anne supported investments in 5 companies which have raised over $200M to date through seed, Series A & B financings and listing on EuroNext.

Anne is a member of the evaluation committee at Paris Biotech Santé (Paris incubator) and a member of the investment committee of Pulsalys (SATT Lyon St-Etienne).